ANKRD58 Inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of the ANKRD58 (Ankyrin Repeat Domain-containing Protein 58) protein, a member of the ankyrin repeat family known for its involvement in protein-protein interactions. The ankyrin repeat domain is a common protein motif that mediates protein interactions, playing critical roles in various cellular processes, including signal transduction, cell cycle regulation, and structural integrity. ANKRD58 Inhibitors function by binding to the ankyrin repeat domains of the ANKRD58 protein, thereby blocking its ability to interact with other proteins. This inhibition is typically achieved through the precise molecular design of the inhibitor, which is tailored to fit into the binding grooves of the ankyrin repeat domains. By occupying these grooves, the inhibitors prevent the ANKRD58 protein from engaging in its normal interactions, which can lead to downstream effects on the cellular processes that ANKRD58 is involved in.
The effectiveness of ANKRD58 Inhibitors is largely determined by their chemical structure and properties. These inhibitors often possess specific structural features that allow them to bind tightly and selectively to the ankyrin repeat domains of ANKRD58. For instance, the inhibitors may include hydrophobic groups that interact with non-polar regions of the protein, as well as polar or charged functional groups that form hydrogen bonds or electrostatic interactions with key residues within the binding site. The solubility, stability, and overall molecular geometry of these inhibitors are optimized to ensure they can effectively reach and bind to ANKRD58 in the complex environment of the cell. Additionally, the kinetics of binding-how rapidly and strongly the inhibitor associates with and dissociates from ANKRD58-play a crucial role in determining the inhibitor's impact on the protein's function. Understanding these interactions provides valuable insights into the regulatory mechanisms of protein-protein interactions within cells and highlights the specific role of ANKRD58 in various cellular pathways.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
Inhibits CDK4/6 involved in the regulation of cell cycle progression, which can inhibit the function of cell cycle-related proteins including sosondowah ankyrin repeat domain family member D. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Inhibits histone deacetylase (HDAC) which can lead to changes in chromatin structure and result in the inhibition of proteins involved in the cell cycle and other regulatory pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, thereby inhibiting downstream AKT signaling which can inhibit proteins associated with cell survival and growth, potentially including sosondowah ankyrin repeat domain family member D. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which can reduce the activity of transcription factors and inhibit the function of proteins involved in cell stress responses. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK, which can prevent the activation of MAPK/ERK pathway and inhibit the function of proteins regulated by this pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, which can lead to the inhibition of downstream proteins that are regulated by stress-activated protein kinase pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which can lead to the inhibition of proteins involved in cell growth, proliferation, and survival pathways. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which can lead to the inhibition of downstream proteins in the PI3K/AKT signaling pathways. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which can inhibit downstream ERK activation and thereby inhibit the function of proteins regulated by the MAPK pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, which can result in the inhibition of proteins involved in cell shape, motility, and contraction. | ||||||